Last Price | 2.78 | Max Price | 3.04 |
Min Price | 0.19 | 1 Year return | 75.95 |
Sector | Health Care | Subsector | Health Care Eq. & Services |
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 21 | 2,019,579 | 0.00 % |
2020 | 11 | 2,170,517 | 0.00 % |
2021 | 17 | 2,404,876 | 0.00 % |
2022 | 25 | 2,645,792 | 0.00 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
No Records Found
Streamline Health Solutions is active in the health care eq. & services sector. Between 2006 and 2016 the global health care companies gained around 102 percent. As from 2011 the sector is 64 percent higher and over the past 12 months (December 2015-December 2016) there is a plus of 102 percent.
The American company didn't pay out any dividends (in the past 5 years).
At the end of 2015 the American company had a balance sheet of around 50,15 million dollars. Last year the total debt of the company was 26,15 million dollars. This equals around 52,14 percent of the total balance sheet. The American company's price/earnings-ratio was -14. So the market valued the stock at -14 times the 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.
At the end of 2015 the health care company's market size (her number of outstanding share times the stock price) equaled around 32,71 million dollars. At the end of 2015 the American company had around 18,69 million stocks listed.
All Streamline Health Solutions's annual reports can be found here. More information about Streamline Health Solutions can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
28
|
27
|
24
|
22
|
21
|
11
|
Costs |
34
|
33
|
27
|
28
|
19
|
11
|
Profit |
-6
|
-6
|
-3
|
-6
|
2
|
|
Margin of profit |
-19.89
|
-22.32
|
-12.74
|
-26.24
|
9.79
|
2.64
|
ROI |
-23.46
|
-29.19
|
-16.58
|
-39.42
|
12.68
|
1.72
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
24
|
21
|
19
|
15
|
16
|
17
|
Debt |
26
|
21
|
18
|
17
|
16
|
8
|
Total assets |
50
|
42
|
37
|
32
|
32
|
26
|
Solvency |
47.86
|
49.69
|
50.36
|
46.91
|
50.50
|
67.32
|
Cash |
10
|
6
|
5
|
2
|
2
|
2
|
Cashflow |
6
|
1
|
2
|
1
|
0
|
-6
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.22
|
0.05
|
0.11
|
0.08
|
0.0
|
-0.68
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
1.41
|
1.25
|
1.69
|
0.81
|
1.39
|
Eps |
-0.31
|
-0.16
|
-0.30
|
0.09
|
0.01
|
Price/earnings-ratio |
-4.55
|
-7.81
|
-5.63
|
9.00
|
278.00
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
1.05
|
0.93
|
0.72
|
0.52
|
0.55
|
Market to book |
0.75
|
0.75
|
0.42
|
0.65
|
0.20
|
Cashflow per stock |
0.05
|
0.10
|
0.07
|
0.0
|
-0.18
|
Stocks |
20
|
20
|
21
|
31
|
32
|
Market Cap |
27.77
|
25.01
|
35.10
|
24.73
|
87.84
|
Date
|
Price
|
---|---|
29 Nov 2024
|
2.78
|
27 Nov 2024
|
3.04
|
13 Nov 2024
|
2.61
|
08 Nov 2024
|
2.73
|
05 Nov 2024
|
2.22
|
31 Oct 2024
|
2.25
|
29 Oct 2024
|
2.09
|
23 Oct 2024
|
2.10
|
19 Oct 2024
|
2.28
|
16 Oct 2024
|
2.31
|
14 Oct 2024
|
2.36
|
05 Oct 2024
|
2.57
|
02 Oct 2024
|
0.23
|
27 Sep 2024
|
0.23
|
20 Sep 2024
|
0.20
|
17 Sep 2024
|
0.19
|
13 Sep 2024
|
0.25
|
28 Aug 2024
|
0.57
|
26 Aug 2024
|
0.53
|
23 Aug 2024
|
0.58
|
11 Aug 2024
|
0.47
|
07 Aug 2024
|
0.49
|
05 Aug 2024
|
0.45
|
01 Aug 2024
|
0.52
|
30 Jul 2024
|
0.50
|
26 Jul 2024
|
0.49
|
23 Jul 2024
|
0.49
|
16 Jul 2024
|
0.51
|
10 Jul 2024
|
0.50
|
09 Jul 2024
|
0.47
|